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OBJECTIVES: Both Low Anterior Resection (LAR) and Abdominoperineal Resection
(APR) procedures are utilized to treat rectal tumors. There may be occasions when
methods or devicesmay be utilized that could preserve communication to the anus
and avoid conversion of an LAR to APR. We seek to compare the costs of LAR and
APR procedures in comparable patient populations. METHODS: The Premier Per-
spective™ Database (PPD) was used to estimate the incidence and costs of LAR
versus APR in the United States. PPD is the largest hospital-based, database in the
USA providing detailed resource utilization and cost data categorized under a pa-
tients’ principal and secondary diagnosis procedure codes. Patientswith procedure
code for LAR or APR procedures between January 1, 2009 to June 30, 2010 were
selected. RESULTS: A total of 7999 patients with a procedure code for either LAR or
APR were identified between January 1, 2009 and June 30, 2010. APR was used in
1991 (25%) patients and LAR in 6008 (75%) patients. Propensity score methodology
was used to match LAR patients to APR patients based on patient’s demographics
and hospital characteristics. Mean cost per discharge was significantly higher in
APR procedures compared to LAR procedures, $24,922 versus $21,709, respectively,
p0.0004.OR timewasapproximately 54minutes shorter for patientsundergoing LAR
compared to patientswithAPRprocedures, 250minutes vs. 304minutes, respectively,
(p0.001). Patients undergoing LAR procedures had a significantly shorter hospital
length of stay, compared to patients who underwent APR procedures, 9 days versus
10.4 days, respectively, p0.001. CONCLUSIONS: LAR procedures were associated
with shorter hospital lengths of stay, lower OR time and lower mean costs when
compared to a matched set of patients undergoing APR procedures. These observa-
tions highlight the potential cost advantages of further developingmethods or instru-
mentation that would preserve anal function and avoid an APR.
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OBJECTIVES: Bariatric surgical procedure volumes have increased as more hospi-
tals offer the service. Strictures following bariatric surgery using circular staplers
are a common complication. The objective was to assess the cost of gastrointesti-
nal strictures following laparoscopic bariatric surgery that employed circular sur-
gical staplers in the index procedure. METHODS: Laparoscopic bariatric surgery
inpatient discharges (ICD-9-CM:44.31, 44.39) withmention of circular staplers were
identified in the Premier Perspective® Database for CY2008 and CY2009. Esopha-
geal balloon dilation procedure codes (CPT:43235, 43245; ICD-9-CM:44.22) for inpa-
tient and outpatient discharges were used to identify single or multiple strictures
within 6 months following bariatric surgery. Groups were propensity score
matched (1:1) on age, gender, race, region, hospital teaching status and APR-DRG
severity. The initial bariatric surgery costs, hospital length of stay (LOS) and oper-
ating room (OR) time between the stricture and no-stricture groupswere compared
between thematched groups. The cost of strictureswas assessed for patients in the
stricture group. RESULTS:A total of 4,731 laparoscopic bariatric surgery discharges
utilizing circular staplers were identified. 201(4.3%) of these had a mention of at
least one balloon dilation procedure within 6 months of the index procedure. 170
(84.6%) and 31(15.4%) were performed in outpatient and inpatient settings, respec-
tively. 200 patients were propensity matched between the stricture and no-stric-
ture groups. There were no significant differences in initial bariatric surgery costs,
LOS and OR time between groups .For the outpatient setting; mean total costs of 1st
(N169), 2nd (N29), 3rd (N7) and the 4th stricture (N3) were $1251, $1025, $1603
and $1610 respectively. One patient had more than 4 strictures. For the inpatient
setting, mean total cost was $7110 for the 1st (N31) stricture. CONCLUSIONS: Post
surgical strictures can increase treatment costs for laparoscopic bariatric surgery
patients utilizing circular staplers.
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OBJECTIVES: To compare demographics, clinical characteristics, and healthcare
costs and utilization between patients receiving total knee replacement (TKR) with
and without muscle atrophy/weakness (MAW).METHODS:Medical and Pharmacy
claims from a U.S. population with commercial or Medicare supplemental insur-
ance were analyzed to select patients aged 50 receiving TKR (first hospitalization
as the index stay) between January 1, 2006-September 30, 2009. Three cohorts were
constructed: patients with MAW medical claims in 1 year before the index stay
(pre-MAW), patients with first MAW claim during or within the 12-month after the
index stay (post-MAW), and patients without any MAW claim (no-MAW). Baseline
demographic and clinical characteristics, and health care costs and utilization
during 1 year prior to and after the index stay were assessed. Multivariate regres-
sion analyses were performed to compare health care costs incurred within 1 year
after the index stay between cohorts. RESULTS: There were 46,058 Medicare (pre-
MAW: 508; post-MAW: 1,939; no-MAW: 43,611) and 53,696 commercially-insured (pre-
MAW: 470; post-MAW: 2,742; no-MAW: 50,484) patients included in this study. Pre-
MAW patients were more likely to have any hospitalizations (Medicare: 35.4% vs.
15.7% vs. 13.2%; commercial: 24.9% vs. 10.4% vs. 9.1%) during the 1 year pre-index stay
than those in the post-MAW and no-MAW cohorts (all P0.05). The average annual
health care costs for Medicare patients before the index stay were $25,335 (standard
deviation [SD]: 30,047), $15,039 (SD: 21,357), and $12,547 (SD: 19,807) for pre-MAW,
post-MAW, and no-MAWcohorts, respectively, and the numbers for the commercial-
ly-insured patientswere $27,571 (SD: 32,761), and $13,131 (SD: 17,512) and $12,602 (SD:
17,786). Adjusting for demographic and clinical characteristics, both pre-MAW and
post-MAW cohorts had significantly higher total health care costs (Medicare: $4,201
and$9,404; commercial: $2,737 and$66,640) than theno-MAWcohort (all p0.01) over
the 12-month post-index stay.CONCLUSIONS: PatientswithMAWhadhigher health
care costs after TKR than patients without.
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OBJECTIVES: Video-assisted thoracic surgery (VATS) is an emerging alternative for
selected non-small cell lung cancer (NSCLC) patients. In this cost-effectiveness
analysis, we used patient-level data to compare VATS and open surgery for newly
diagnosed stage I NSCLC patients. METHODS: Using information from the cancer
registry, mortality data, and claims data in the Collaboration Center of Health
Information Application database in Taiwan, we identified patients with newly
diagnosed stage I NSCLC received primary lung resection in 2007 and defined the
index date as the date of admission for the index surgery. We compared the cost,
effectiveness, and cost-effectiveness of VATS vs. open surgery within 1 year after
the index date in this retrospective cohort study. The study was conducted from a
payor’s (i.e.,Taiwanese National Health Insurance Program) perspective. All costs
were converted to 2011 US dollars using the local consumer price index and pur-
chasing power parity. We included patient sociodemographics factors, provider
characteristics, and clinical variables as explanatory variables. We used the pro-
pensity score bin bootstrappingmethod for 1000 times to obtain the distribution of
the incremental cost-effectiveness ratio (ICER, in US dollars/life-years (USD/LY))
and to get a better matching of case vs. control by using the above explanatory
variables. RESULTS: We identified 329 patients with newly diagnosis NSCLC; 114
patients received VATS. VATS is associated with higher mean effectiveness (0.972
vs. 0.965 LY) and higher cost ($19,679 vs. $18,996 USD). The estimated mean ICER
was $765,19/LY, and the probability that VATS is more cost-effective at $50,000-
100,000/LY is 41-56%. CONCLUSIONS: This short-term CEA suggested that for
newly diagnosed stage I NSCLC patients VATS is likely to be cost-effective when
compared to open surgery. The result should be interpreted with caution because
of potential endogeneity in treatment selection, and the small absolute difference
and wide confidence interval observed in our data.
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OBJECTIVES: Cystic fibrosis (CF) is a chronic, progressive and recessive genetic
disorder affecting one in every 2000 newborns. A frequent and life threatening
complication reported in patientswith CF is ‘Pneumothorax’ and is associatedwith
significant economic burden. Chest tube drainage, Thoracotomy, and Thoracoscoy
are the choice of treatment for pneumothorax in patients with CF. The objective of
this study was to determine the cost-effectiveness of Thoracoscopic Pleural Abra-
sion (TPA) and Thoracoscopic Talcage (TT) for treatment of pneumothorax in pa-
tients with CF. METHODS: Cost-effectiveness analysis was conducted using effi-
cacy data and costs associated with adverse events (ADE) obtained from literature
review including clinical trials and meta-analysis studies. Direct medical costs
included cost of procedures, hospitalization and those associated with ADEs. All
costs were obtained for a period of one year from US third party perspective and
adjusted to 2011 USD using consumer price index. Effectiveness operationalized as
success rate (no recurrence within one year) was evaluated by developing a deci-
sion tree model using TreeAge Pro 2009. One way sensitivity analysis was per-
formed onADE and total cost for each therapy. Incremental cost-effectiveness ratio
(ICER) was computed to compare procedures. RESULTS: Success rate over one year
periodwas found 91.9% for TPA and 95% for TT. Total cost of treatment for TPA and
TT was found to be $2535 and $3614, respectively. The expected cost of treatment
per unit change for TPA was $27.58 while that of TT was $38.04. An ICER demon-
strated TT ($3614) to be more costly than TPA ($2535). Sensitivity analyses per-
formed were robust to the results. CONCLUSIONS: Thoracoscopic Pleaural Aabra-
sion was more cost-effective than Thoracoscopic Talcage for treatment of
pneumothorax in patients with CF, from US third party perspective in our study.
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OBJECTIVES: Perform a cost-effectiveness analysis to evaluate laparoscopic roux-
en-y gastric bypass(LRYGB) and banding procedures(LAGB) against each other and
no treatment. METHODS: A backwards induction cost-effectiveness model was
utilized and analysis was conducted from a societal perspective. Lifetime costs and
life expectancies for LRYGB, LAGBmorbidly obese patientswere compared to those
on no treatment and to each other. Efficacy and probabilities estimates were ob-
tained from a literature review. Costs and quality-adjusted life years(QALYs) were
discounted by a 3% annual rate, and costs are reported in 2011 US dollars. A one-
way sensitivity analyses was done to assess the model’s robustness. RESULTS:
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LRYGB had the greatest lifetime costs at every age ($13,506 vs. no treatment, $3,859
vs. LAGB), but also the greatest amount of QALYs gained (2.54 more vs. no treat-
ment, 1.32 vs. LAGB), leading to a lower ICER than LAGB when compared with no
treatment ($5,324 and $7943/QALY, respectively). When LRYGB was compared to
LAGB, a relatively low ICER of $2,918/QALY resulted at age 40. ICERs in both compari-
sons increased steadilywith age. In one-way sensitivity analyses for LRYGBagainst no
treatment, the most sensitive parameters were medical costs associated with initial
baseline BMI (ICER varied 187%), and medical costs associated with LRYGB efficacy
(80%). The results of LAGB against no treatment were similar, although utility asso-
ciated with efficacy was much more sensitive in comparison. In results for LRYGB
versus LAGB, the model was most sensitive to recurring medical cost parameters
associated with efficacy of treatment. CONCLUSIONS: Both LRYGB and LAGB were
found to be cost-effective compared to no treatment for morbidly obese people,
with ICERs below $25,000 up to age sixty. These results were robust to reasonable
model parameter changes. This study also suggests that LRYGBmay bemore cost-
effective than LAGB due to the relative improvement in QALYs gained.
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OBJECTIVES: To evaluate the cost-effectiveness of bariatric surgery in obese Ko-
rean people. METHODS: The target population was obesity patients defined as
having a body mass index (BMI) of BMI30kg/m2 with diabetes. This study per-
formed in Healthcare system perspectives. The bariatric surgery comprised lapa-
roscopic adjustable gastric banding (LAGB), Roux-en Y gastric bypass (RYGB), and
Sleeve gastrectomy (SG). The comparison, non-surgical treatments consisted of
physician visit, exercise, diet, and pharmacotherapy. For cost-effectiveness anal-
ysis, the decision model with a one year time horizon was used. The effectiveness
associated with percent weight change from baseline, BMI reduction, and propor-
tion of patients with more than 10% weight change. The cost data was collected
from the survey of 9 medical centers who had conducted these obesity treatments
and Korean national health insurance statistics, based on 2011 costs. The effective-
ness data and distribution of surgery and complication was collected from 7multi-
center, 485 patients retrospective chart review. Incremental cost-effectiveness ra-
tio (ICER) of bariatric surgery compared to non-surgery interventions was
calculated in obese people. Subgroup analysis using various BMI levelwith/without
diabetes and probability sensitivity analysis were conducted to assess the stability
of base-case results. RESULTS: The bariatric surgery had higher cost (US$9273) and
better effectiveness(18.1% weight loss), the Incremental cost-effectiveness ratio
(ICER) was US$512 per one-percent weight loss. Through the subgroup and sensi-
tivity analysis under various conditions, robustness of the study results was also
demonstrated. CONCLUSIONS: The cost-effectiveness study for clinical outcomes
indicated that bariatric surgery was clinical and cost effective alternative to con-
ventional therapy in obese patients.
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OBJECTIVES: The purpose of this study was to assess the cost-utility of bariatric
surgery compared to non-surgical interventions in obese Korean people.
METHODS: We used Markov model comparing the lifetime expected costs and
quality adjusted life years (QALY) between bariatric surgery and non-surgery in-
tervention from Korean Healthcare system perspectives. Our target cohort con-
sisted of obese people defined as having a body mass index (BMI) of 30-40 in South
Korea. The starting age of cohort was 30 years old. The non-surgical interventions
include physician visit, exercise, diet, and pharmacotherapy. The cycle length was
1 year and used half-cycle correction. The health status comprised five states such
as no comorbidity, mild/moderate comorbidity (diabetes or/and hypertension or/
and, dyslipidemia), severe comorbidity (CHD or/and stroke), death due to CVD, and
death due to other cause. Input data of transition probability for eachdisease status
and utility weight calculated from the relationship between weight loss and QALY
gain using Korean National Health and Nutrition Examination Survey data. The
rate of death due to CVD and other cause were calculated Korean death statistics.
The cost datawas collected from the survey of 9medical centerwhohad conducted
those obesity treatments and Korean national health insurance statistics, based on
2011 costs. Discount of 5% was applied in cost and QALY. Incremental cost-effec-
tiveness ratio (ICER) of bariatric surgery compared to non-surgery interventions
was calculated. RESULTS: The cost-utility study indicated that bariatric surgery
had US$1,522 Incremental costs and 0.86 Incremental QALY compared non-surgi-
cal interventions. Through the base case analysis, ICER was US$1771/QALY. The
sensitivity analyses under a variety of assumption, robustness of the study results
were also demonstrated. CONCLUSIONS: The study indicated that bariatric sur-
gery was cost-effective alternative to non-surgical interventions over lifetime, pro-
viding substantial lifetime benefits in obese Korean people.
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OBJECTIVES: To assess differences in demographics, comorbidities, and healthcare
costs and utilization among patients undergoing total hip replacement (THR) surgery
with and without muscle atrophy/weakness (MAW).METHODS: Using large US ad-
ministrative claims databases, we examined individuals aged 50 with commer-
cial insurance or Medicare supplemental insurance whowere hospitalized for THR
between January 2006 to September 30, 2009. The first hospitalization was defined
as the index stay. Three cohorts were further identified based on whether individ-
uals had medical claims associated with MAW over the 12 months pre-index stay
(pre-MAW), patients whose first MAW claim occurred during or within the 12
months after the index stay (post-MAW), or patients without any MAW claim (no-
MAW). Demographics and comorbidities during 1 year prior to the index stay, and
health care utilization and costs during 1 year before and after the index stay were
compared among groups. Multivariate regressions were performed to estimate
1-year post-indexmedical costs controlling for cross-cohort differences. RESULTS:
There were 23,127 commercially-insured (pre-MAW: 323; post-MAW: 1,176; no-MAW:
21,628) and19,607Medicare (pre-MAW:332;post-MAW:909;no-MAW:18,366)patients
identified. Compared with commercially-insured patients in the post-MAW and no-
MAW cohorts, individuals in the pre-MAW cohort were more likely to have any hos-
pitalization during the 12 months pre-index stay (33.4% vs. 12.7% vs. 10.5%; both
p0.05), ahigherCharlsoncomorbidity indexscore (5.5vs. 4.3vs. 3.9; bothp0.05), and
higher total costs ($35,022 vs. $15,011 vs. 12,952; both p0.05). Controlling for cross-
cohort differences, both pre-MAW and post-MAW cohorts had significantly higher
totalhealthcare costs ($6697and$8593) than theno-MAWcohort (bothp0.01) during
the 12 months post-index stay. Similar trends were observed in the Medicare
population. CONCLUSIONS: Among US patients receiving THR surgery, those with
MAW had higher health care costs than patients without MAW.
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OBJECTIVES: This is an exploratory analysis of potential variables associated with
roux-en-Y gastric bypass (RYGB) surgery hospitalization resource use pattern.
METHODS: Cross-sectional study based on a public database (DATASUS) records.
Inclusion criteria were patients undergoing RYGB between January 2008 and June
2011. Dependent variableswere length of stay and ICUneed. Independent variables
were: gender, age at surgery (continuous or categorized as older/younger than 60),
hospital volume (high volume: 100 RYGB/year; low volume: 100 RYGB/year),
surgery at certified center of excellence (CoE) by the American Society forMetabolic
and Bariatric Surgery (ASMBS) (yes/no), year of hospitalization. Univariate and
multivariate analysis (logistic regression for ICU need and linear regression for
length of stay) were performed. RESULTS: Data from 13,069 surgeries were ana-
lyzed. 14.8% of patients were male, mean age 38.210.4 years, 52.2% undergone
surgery in a high volume hospital, 11.6% from a certified CoE by ASMBS. In the
univariate analysis of potential factors associated with outcomes of interest, the
variable with highest effect size for length of stay was hospital volume (high vol-
ume 3.81.8 days vs 6.37.6 low volume, p0.001), whereas for ICU need it was
certified CoE (50.0% vs. 1.3%, p0.001). Final model for ICU need after logistic re-
gression includes certified CoE (OR 0.009, CI95% 0.006-0.014), hospital volume (OR
3.16, CI95% 2.93-3.41) and age group (OR 1.93, CI95% 1.46-2.57). Themost important
variable in the final model for log-transformed length of stay is hospital volume
(adjusted coefficient -0.338, CI95% -0.379 to -0.297); association was also found for
certified CoE, gender and age. In high volume hospitals, variance of RYGB length of
stay is significantly lower than variance in low volume hospitals (SD 2.1 vs. 11.0,
p0.001). CONCLUSIONS: High volume hospitals are strongly associated with
shorter length of stay and less variability, and ASMBS certification is strongly as-
sociated with less need for ICU.
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THE IMPORTANCE OF MEDICAL APPOINTMENTS AFTER ROUX-EN-Y GASTRIC
BYPASS IN MORBID OBESE PATIENTS: ASSOCIATION BETWEEN ADHERENCE TO
MEDICAL FOLLOW-UP VISITS AND THE BARIATRIC ANALYSIS AND REPORTING
OUTCOME SYSTEM (BAROS) SCORE BASED ON AN ADMINISTRATIVE
DATABASE (DATASUS) IN BRAZIL
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OBJECTIVES: Correct clinicalmanagement ofmorbid obese patients does not begin
and neither ends with bariatric surgery. The aim of this study was to evaluate the
association between number of medical follow-up visits after surgery and patient
outcomes in morbid obese patients undergoing roux-en-Y gastric bypass (RYGB).
METHODS: This is a database (DATASUS) retrospective cohort study. Inclusion
criteria was patients undergoing RYGB between January 2008 and June 2010with at
least one medical follow-up visit. The dependent variable was the Bariatric Anal-
ysis and Reporting Outcome System (BAROS) score, which combines clinical (%Ex-
cess weight loss, co-morbidity resolution) and quality of life outcomes in one cat-
egorical variable (failure/fair/good/very good/excellent). Independent variable was
adherence tomedical follow-up visits, adjusted for potential covariates. Univariate
and multivariate analysis (by linear regression) were performed at 12 and 24
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